HMG 150IU

What is Dragon Pharma HMG?
HMG (Human Menopausal Gonadotropin) is a purified gonadotropin peptide derived from the urine of postmenopausal women, containing both follicle-stimulating hormone (FSH) and luteinizing hormone (LH). It is widely studied for its ability to stimulate ovarian follicle development and spermatogenesis. In research settings, HMG is used to investigate reproductive endocrinology, fertility treatments, and hormone regulation, providing insights into controlled gametogenesis and reproductive function in experimental medicine.

Mechanism of Action:
HMG functions by delivering both FSH and LH activity, which bind to their respective receptors in the gonads. FSH stimulates follicular growth and spermatogenesis, while LH promotes steroidogenesis and ovulation. This dual activity increases gonadal hormone production, enhances gamete maturation, and supports reproductive capacity. Its mechanism is valuable for research in fertility therapies, hormonal modulation, and endocrine physiology.

Benefits:

• Stimulates ovarian follicle development and maturation.

• Enhances spermatogenesis and male reproductive hormone function.

• Supports controlled ovulation and hormone regulation in research models.

• Provides a model for studying reproductive endocrinology and fertility interventions.

Research Applications:

• Investigating assisted reproductive technologies and ovulation induction.
• Studying spermatogenesis and male fertility modulation.
• Exploring the regulation of FSH and LH in endocrine research.
• Researching hormone therapy and reproductive health interventions.

Dosing Instructions:

• Dosing: Reconstitute HMG with sterile water according to research protocol, gently swirling to ensure complete dissolution.
• Daily Dose: Typically 75–150 IU per day depending on experimental objectives and protocol guidelines.
• Route: Subcutaneous or intramuscular injection for optimal bioavailability and gonadal stimulation.
• Duration: Research cycles commonly last 7–14 days or per study-specific protocols to observe follicular or spermatogenic responses.
• Frequency: Administered once daily, with timing adjusted to align with endogenous reproductive cycles in research models.
• Recommended Cycles: One or more cycles per experimental study, with monitoring of gonadal response and hormone levels.
• PCT: Post-cycle therapy is usually not required; monitoring of reproductive hormone levels is recommended.

Stacking With Other Products:

• hCG (Human Chorionic Gonadotropin) to support testosterone production and enhance spermatogenesis.
• FSH analogs for targeted ovarian or testicular stimulation in experimental studies.
• GnRH analogs to regulate endogenous LH/FSH secretion during reproductive research.
• Clomiphene Citrate to modulate feedback mechanisms and optimize hormonal outcomes in fertility studies.

Side Effects:

• Injection-site pain, redness, or irritation.
• Headaches or mild hormonal fluctuations in sensitive subjects.
• Ovarian hyperstimulation in female models if dosing is excessive.
• Rare gastrointestinal discomfort or fatigue during experimental protocols.

Contraindications:

• Hypersensitivity to HMG or any excipients in the formulation.
• Pregnant women not under controlled research conditions.
• Uncontrolled endocrine disorders affecting gonadal or pituitary function.
• Severe renal or hepatic impairment without careful monitoring.

Conclusion
HMG is a key peptide in reproductive research, offering robust FSH and LH activity to stimulate gametogenesis, follicular development, and steroidogenesis. Its dual mechanism provides a reliable model for studying fertility, hormone regulation, and reproductive endocrinology. When used responsibly in research, HMG enables precise modulation of ovarian and testicular function, providing valuable data for fertility interventions, assisted reproductive technologies, and endocrine studies. Proper dosing, administration, and monitoring are critical for optimizing research outcomes and safety.

References:

• Filicori, M., et al. "Human Menopausal Gonadotropin: Clinical and Research Applications." Fertility and Sterility. 1999;72(2):209–221.
• De Leo, V., et al. "HMG and its role in ovulation induction and spermatogenesis." Journal of Endocrinological Investigation. 2006;29(5):439–447.
• ClinicalTrials.gov Identifier: NCT00767228 – HMG in assisted reproductive technology research.
• Griesinger, G., et al. "Comparative studies of FSH and HMG in fertility research." Human Reproduction Update. 2011;17(6):734–747.

HMG (Human Menopausal Gonadotropin) – FAQ

✔️ What is HMG (Human Menopausal Gonadotropin)?
HMG is a purified gonadotropin peptide containing FSH and LH, widely used in research to study reproductive hormone signaling and fertility pathways.

✔️ How does HMG work?
It stimulates the gonads by activating FSH and LH receptors, promoting follicular development, gametogenesis, and reproductive endocrine responses in experimental models.

✔️ What are the recommended storage conditions?
Store the lyophilized powder at 2–8°C, protected from light and moisture. Reconstituted solution should be refrigerated and used within the experimental timeframe.

✔️ Is HMG safe for laboratory research?
Yes, when used under controlled research protocols, HMG is safe for preclinical studies. It is strictly for laboratory use and not intended for human consumption.

✔️ Can HMG be stacked with other peptides or hormones?
Yes, it is often studied in combination with HCG, FSH analogs, and other reproductive peptides to examine synergistic effects on gametogenesis and hormonal feedback loops.

✔️ How long is HMG stable after reconstitution?
After reconstitution with sterile diluent, the solution should be stored refrigerated at 2–8°C and used within 7–14 days depending on research protocol.

Storage and Safety – HMG (Human Menopausal Gonadotropin)

Proper storage and handling of HMG (Human Menopausal Gonadotropin) are essential to preserve its bioactivity, stability, and research accuracy. The lyophilized powder should be stored in a refrigerated environment at 2–8°C (36–46°F) and kept protected from light and moisture. Avoid freezing the vial, as temperature fluctuations can compromise the peptide’s structural integrity and potency.

After reconstitution with a sterile bacteriostatic diluent, the solution should be stored refrigerated and used within the recommended time frame outlined in experimental protocols, typically within 7–14 days. Ensure all handling uses sterile techniques to prevent contamination.

Safety precautions include wearing gloves and lab attire, avoiding contact with skin or eyes, and handling the product in a controlled laboratory environment. Dispose of used vials, syringes, and materials according to biohazard waste guidelines. This product is strictly for laboratory research and experimental purposes and is not intended for human consumption.

Summary: Maintaining proper refrigeration, sterility, and light protection ensures that HMG (Human Menopausal Gonadotropin) remains fully active, safe, and reliable for all experimental research involving gonadotropin signaling, fertility, and endocrine studies.